Clinical studyLipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma
References (31)
The pathogenesis and clinical significance of xanthelasma palpebrarum
J Am Acad Dermatol
(1994)- et al.
Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum
Atherosclerosis
(1981) Xanthelasma and hyperlipoproteinaemia
Clin Chim Acta
(1976)- et al.
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
J Lipid Res
(1982) - et al.
Determination of B protein of low density lipoprotein directly in plasma
J Lipid Res
(1975) - et al.
Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis
Atherosclerosis
(1987) Lipoprotein physiology and its relationship to atherogenesis
Endocrinol Metab Clin North Am
(1990)- et al.
Xanthelasma et dyslipoprotéinémie: présentation de deux études retrospectives
Ann Dermatol Venereol (Paris)
(1982) - et al.
The association of dyslipoproteinemia with corneal arcus and xanthelasma
Circulation
(1986) - et al.
Apolipoprotein E phenotipes, lipoprotein composition, and xanthelasmas
Arch Dermatol
(1988)
Dyslipoproteinemia in patients with xanthelasma
Arch Dermatol
Xanthelasma: clinical indicator of decreased levels of high-density lipoprotein cholesterol
South Med J
Dyslipoproteinemia in patients with xanthelasma
Arch Dermatol
Xanthelasma palpebrarum
JAMA
Clinical observations regarding xanthelasma
Ann Intern Med
Cited by (46)
Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis
2020, Journal of the American Academy of DermatologyCitation Excerpt :In addition to dyslipidemia, hypertension and diabetes mellitus are both well-established risk factors of CVDs.34 Four studies included in our final meta-analysis also showed the prevalence of hypertension and diabetes mellitus in the patients with XP and in controls, and the prevalence of hypertension and diabetes mellitus in both groups was not significantly different in each study.13,17,18,22 Furthermore, we also found no significant difference in a comparison of prevalence of hypertension (P = .086) and diabetes mellitus (P = .704) when we used pooled analysis between the patients with XP and controls.
Stable angina pectoris
2017, Coronary Artery Disease: From Biology to Clinical PracticeVisible aging signs as risk markers for ischemic heart disease: Epidemiology, pathogenesis and clinical implications
2016, Ageing Research ReviewsCitation Excerpt :Roles of apolipoproteins have also been suggested as an explanation for the increased risk of ischemic heart disease. Some studies have suggested a role for decreased levels of apolipoprotein A1 (Pandhi et al., 2012), increased levels of apolipoprotein B (Douste-Blazy et al., 1982; Pandhi et al., 2012; Ribera et al., 1995; Tursen et al., 2006) and/or increased levels of apolipoprotein E (Douste-Blazy et al., 1982) in the association between xanthelasmata and ischemic heart disease in normolipidemic individuals. Although we observe decreased levels of apolipoprotein A1 and increased levels of apolipoprotein B in individuals with xanthelasmata in the Copenhagen City Heart Study (Fig. 5), this reflects the corresponding changes in HDL cholesterol and LDL cholesterol levels.
Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum
2024, Beyoglu Eye JournalAnimal experimental research of intralesional bleomycin and pingyangmycin in the treatment of xanthoma
2022, Journal of Cosmetic DermatologyClinical and serum lipid profiles and LDLR genetic analysis of xanthelasma palpebrarum with nonfamilial hypercholesterolemia
2020, Journal of Cosmetic Dermatology